Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...
ST. LOUIS, Oct. 21, 2025 /PRNewswire/ -- Peabody (NYSE: BTU) will discuss its third quarter 2025 financial results in an investor conference call on Thursday, Oct. 30, 2025, at 10:00 a.m. Central Time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback